Artiva (ARTV) Director Brian Daniels Receives 13,750-Share Award

What Happened

• Brian Daniels, a director of Artiva Biotherapeutics (ARTV), was granted 13,750 derivative shares (reported as an award) on September 8, 2026. The filing reports an acquisition price of $0.00 per share (derivative award), so no cash was paid in this reported transaction. This is a grant of equity compensation rather than a market purchase or sale.

Key Details

• Transaction date: 2026-09-08
• Transaction type: Award / derivative acquisition — 13,750 shares reported at $0.00 per share
• Filing date: 2026-09-08 (same-day filing)
• Shares owned after transaction: Not specified on this Form 4
• Footnote: The shares subject to the option will vest in full on the earlier of September 8, 2027 or the issuer’s 2027 annual stockholder meeting.
• No sale or exercise reported; this is a standard director compensation grant.

Context

• This is an equity award to a board member, a common form of non-cash compensation for directors. The $0.00 reporting reflects the form of the grant in the filing and does not indicate its economic value or any exercise price. The award is subject to a vesting condition noted above and does not indicate immediate liquidity (no immediate sale or cashless exercise).